HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jeng-Pyng Shaw Selected Research

Respiratory Tract Infections (Respiratory Tract Infection)

1/2008Intrapulmonary distribution of intravenous telavancin in healthy subjects and effect of pulmonary surfactant on in vitro activities of telavancin and other antibiotics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jeng-Pyng Shaw Research Topics

Disease

5Body Weight (Weight, Body)
04/2012 - 08/2004
3Infections
04/2012 - 08/2004
1Glaucoma
02/2013
1Constipation
10/2012
1Respiratory Tract Infections (Respiratory Tract Infection)
01/2008
1Blister (Bulla)
02/2006

Drug/Important Bio-Agent (IBA)

4telavancinFDA Link
04/2012 - 08/2004
1Carbonic Anhydrase IIIBA
02/2013
1ProstaglandinsIBA
02/2013
1TD-5108IBA
10/2012
1cefilavancinIBA
03/2012
1Dihydrotachysterol (AT 10)IBA
01/2008

Therapy/Procedure

1Intravenous Infusions
01/2008